China successfully developed the world's first quantum dot medical detection reagent
Release date: 2016-09-01
The application of quantum technology in the medical field has become possible. There have been studies on quantum technology in China 10 years ago, but there has been no product launch. Recently, a domestic company successfully developed the world's first quantum dot medical detection reagent, which is especially suitable for detecting children with difficult blood collection. Quantum technology will be successfully applied in the medical field.
China successfully launched the world's first quantum satellite shocked Europe and the United States. The world's first quantum dot medical detection reagent, which also uses quantum technology, was born in Baoan. The reagent was unveiled at the first National Severe Neurological Congress held in Changsha from August 18th to 21st, and became the focus of attention of the industry.
Quantum technology has been studied in many fields around the world. As early as ten years ago, there were scientific research institutions trying to apply quantum technology to the medical field. However, as of now, there are still no related products on the market. Five years ago, Shenzhen Daai Medical Technology Co., Ltd., located in Xixiang Street, Bao'an District, noticed the broad prospects of quantum technology products in the field of medical applications, and began to form a team to carry out related product research and development. In order to better promote the transformation of research and development results, the company specially separated the project from the company to establish Shenzhen Jinzhun Biomedical Engineering Co., Ltd., and settled the company in Fuyong Hi-Tech Industrial Park. The chairman of the company, Zhang Jianguo, led more than 40 employees to study hard for two years. Finally, the successful graduate students produced the world's first quantum dot medical detection reagent, the quantum full-quantity rapid detection and analysis system “calcitoninâ€. The company has global independent intellectual property rights to this product, and has obtained more than 30 patented technology certificates.
It is understood that the principle of this product is to use a new generation of biomarker materials with high-efficiency fluorescent quantum dots to perform full quantitative detection and analysis of detection reagents. Quantum dots, also known as nanocrystals, are a nanomaterial. The dimensions of the three dimensions of quantum dots are all below 100 nm, and the movement of internal electrons in all directions is limited. The continuous band structure becomes a discrete energy level structure with molecular characteristics, which can emit fluorescence after being excited. Zhang Jianguo introduced that the procalcitonin detection reagent successfully developed by the company's R&D team using quantum technology is already available for marketing. There are currently 12 related projects undergoing clinical validation experiments, which are expected to be available in 2-3 months. Sales license, in which hypersensitive procalcitonin will be the only detection reagent available in China for peripheral blood (fingertip blood), especially suitable for children with difficult blood collection. Relevant people expect that the company's output value will increase several times, this year may reach 8 million yuan, next year may reach more than 50 million yuan, or 20 billion in 2018.
Recently, the product was unveiled at the first National Severe Neurological Congress, and immediately became the focus of the exhibition. It was praised by experts and peers, and many investment institutions and industry “big names†offered their cooperation intentions.
Source: Baoan Daily
Dried Fruit,Freeze Dried Strawberries,Dehydrated Fruit,Dried Goji Berries
Xi'an Gawen Biotechnology Co., Ltd , https://www.agolyn-bio.com